Cover Image
市場調查報告書

臨床試驗影像處理全球市場預測 ∼2020年:模式 (CT、MRI、PET、超音波、心臟超音波、X光)、使用者、產品、地區分類

Clinical Trials Imaging Market by Modality (CT, MRI, PET, Ultrasound, Echocardiography, X-rays), End User (Pharmaceutical Companies, CROs Medical device Manufacturers), Product (Services, software), and Region - Global Forecast to 2020

出版商 MarketsandMarkets 商品編碼 340677
出版日期 內容資訊 英文 149 Pages
訂單完成後即時交付
價格
Back to Top
臨床試驗影像處理全球市場預測 ∼2020年:模式 (CT、MRI、PET、超音波、心臟超音波、X光)、使用者、產品、地區分類 Clinical Trials Imaging Market by Modality (CT, MRI, PET, Ultrasound, Echocardiography, X-rays), End User (Pharmaceutical Companies, CROs Medical device Manufacturers), Product (Services, software), and Region - Global Forecast to 2020
出版日期: 2015年09月23日 內容資訊: 英文 149 Pages
簡介

全球臨床試驗影像處理市場2015年到2020年預計將有6.25%CAGR、2015年可達7億2487萬美元2020年達9億8153萬美元規模成長。2015年模式分類預估佔有率以CT部門最多。

本報告針對全球臨床試驗影像處理市場調查、提供臨床試驗影像處理服務、軟體種類與概要、各種服務、軟體分類主要動向與市場規模推算和預測、模式、使用者、地區分類主要動向與市場規模算移預測、市場成長各種影響因素分析、競爭環境、主要企業檔案。

第1章 介紹

第2章 調查方法

第3章 摘要整理

第4章 重要考察

  • 全球市場概要
  • 生命循環分析:地區分類

第5章 市場概要

  • 介紹
  • 市場區分
    • 產品分類
    • 模式分類
    • 使用者分類
  • 市場力學
    • 成長推進因素
    • 成長阻礙因素
    • 市場機會
    • 課題
    • 動向

第6章 產品分類市場

  • 介紹
  • 服務
    • 操作影像
    • 閱讀分析
    • 系統&技術支援
    • 臨床試驗設計諮詢
  • 軟體

第7章 模式分類市場

  • 介紹
  • CT
  • MRI
  • 超音波
  • PET
  • X光
  • 心臟超音波
  • 其他

第8章 使用者分類市場

  • 介紹
  • 製藥公司
  • 生技企業
  • 醫療設備製造業者
  • CRO
  • 學術機關、研究機關
  • 其他

第9章 地區分析

  • 介紹
  • 北美
  • 歐洲
  • 亞洲
  • 其他

第10章 競爭環境

  • 介紹
  • 策略概要
  • 主要企業
  • 競爭狀況、動向
    • 合作、合併、協力
    • 收購
    • 投入新產品、產品升級
    • 擴張
    • 其他

第11章 企業檔案

  • 介紹
  • BIOCLINICA, INC.
  • PAREXEL INTERNATIONAL CORPORATION
  • ICON PUBLIC LIMITED COMPANY
  • BIOMEDICAL SYSTEMS CORPORATION
  • VIRTUALSCOPICS, INC.
  • CARDIOVASCULAR IMAGING TECHNOLOGIES, LLC
  • INTRINSIC IMAGING LLC
  • IXICO PLC
  • RADIANT SAGE LLC
  • WORLDCARE CLINICAL, LLC
    • 概要
    • 財務動向
    • 產品、服務
    • 策略
    • 近年發展動向、其他

第12章 附錄

圖表

目錄
Product Code: HIT 3751

The global clinical trials imaging market is expected to USD 981.53 million by 2020 from USD 724.87 million in 2015, at a CAGR of 6.25% between 2015 and 2020. By product, the market includes services & software. The services product segment is further classified into operational imaging services, systems & technology, reader services & design consulting. Based on modality, the market is segmented into CT, MRI, ultrasound, PET, X-rays, ECHO ad other modalities. The CT segment will hold the largest share of the clinical trials imaging market in 2015.

The geographic segments included in this report are North America, Europe, Asia, and Rest of the World (RoW). North America is expected to account for the largest share in the global clinical trials imaging market in 2015. Asia is expected to register the fastest growth.

The growth of this market is mainly driven by growth in pharmaceutical & biotechnology industries, increase in R&D funding and increasing number of CROs. The high growth potential in emerging markets, provides new growth opportunities and development of innovative new imaging modalities, contrast agents, molecular probes & radiopharmaceuticals provides new growth trends to players in the clinical trials imaging market. Rising demand of multimodality imaging technology in clinical trials is the major trend of this market.

A combination of bottom-up and top-down approaches was used to calculate the market sizes and growth rates of the global clinical trials imaging market and its subsegments. All percentage shares, splits, and breakdowns were determined using secondary sources and verified through primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. Primary interviews with key opinion leaders were also used to determine the percentage shares of each subsegment and the relative differences in growth rates. The report provides qualitative insights about growth rates, and market drivers for all subsegments. It maps market sizes and growth rates for each subsegment and identifies segments poised for rapid growth in each geographic segment. The report also includes company profiles of market leaders

Reasons to Buy the Report:

The report will enable both established firms and new entrants to gauge the pulse of the market and to help them make important strategic growth decisions.

The report provides insights on the following:

  • Product Development/Innovation: Product portfolios of the top players in the clinical trials imaging market. Detailed insights on upcoming technologies, research and development activities, and new product launches in the insights on upcoming technologies market
  • Competitive Assessment: In-depth assessment of market shares, strategies, geographic and business segments, and product portfolios of the leading players in the clinical trials imaging market
  • Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the market for various clinical trials imaging across geographies
  • Market Diversification: Exhaustive information about new products, recent developments, and investments in the clinical trials imaging market

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. MARKET SCOPE
    • 1.3.1. MARKETS COVERED
    • 1.3.2. YEARS CONSIDERED IN THE REPORT
  • 1.4. CURRENCY
  • 1.5. LIMITATION
  • 1.6. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. MARKET SIZE ESTIMATION
  • 2.2. MARKET BREAKDOWN AND DATA TRIANGULATION
  • 2.3. MARKET SHARE ESTIMATION
    • 2.3.1. KEY DATA FROM SECONDARY SOURCES
    • 2.3.2. KEY DATA FROM PRIMARY SOURCES
    • 2.3.3. ASSUMPTIONS FOR THE STUDY

3. EXECUTIVE SUMMARY

4. PREMIUM INSIGHTS

  • 4.1. GLOBAL CLINICAL TRIALS IMAGING MARKET OVERVIEW
  • 4.2. LIFE CYCLE ANALYSIS, BY REGION (2015-2020)

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. MARKET SEGMENTATION
    • 5.2.1. BY PRODUCT
    • 5.2.2. BY MODALITY
    • 5.2.3. BY END USER
  • 5.3. MARKET DYNAMICS
    • 5.3.1. DRIVERS
      • 5.3.1.1. Increase in R&D spending
      • 5.3.1.2. Growth in the pharmaceutical and biotechnology industries
      • 5.3.1.3. Increasing number of CROs
    • 5.3.2. RESTRAINTS
      • 5.3.2.1. High implementation cost of imaging systems
    • 5.3.3. OPPORTUNITIES
      • 5.3.3.1. Emerging economies
      • 5.3.3.2. Development of innovative imaging modalities, contrast agents, molecular probes, & radiopharmaceuticals
    • 5.3.4. CHALLENGES
      • 5.3.4.1. High cost of clinical trials
      • 5.3.4.2. High cost of PET
    • 5.3.5. TRENDS
      • 5.3.5.1. Rising demand for multimodality imaging technology in clinical trials

6. CLINICAL TRIALS IMAGING MARKET, BY PRODUCT

  • 6.1. INTRODUCTION
  • 6.2. SERVICES
    • 6.2.1. OPERATIONAL IMAGING
    • 6.2.2. READ ANALYSIS
    • 6.2.3. SYSTEM AND TECHNICAL SUPPORT
    • 6.2.4. TRIAL DESIGN CONSULTING
  • 6.3. SOFTWARE

7. CLINICAL TRIALS IMAGING MARKET, BY MODALITY

  • 7.1. INTRODUCTION
  • 7.2. COMPUTED TOMOGRAPHY
  • 7.3. MAGNETIC RESONANCE IMAGING
  • 7.4. ULTRASOUND
  • 7.5. POSITRON EMISSION TOMOGRAPHY
  • 7.6. X-RAY
  • 7.7. ECHOCARDIOGRAPHY
  • 7.8. OTHER MODALITIES

8. CLINICAL TRIALS IMAGING MARKET, BY END USER

  • 8.1. INTRODUCTION
  • 8.2. PHARMACEUTICAL COMPANIES
  • 8.3. BIOTECHNOLOGY COMPANIES
  • 8.4. MEDICAL DEVICE MANUFACTURERS
  • 8.5. CONTRACT RESEARCH ORGANIZATIONS
  • 8.6. ACADEMIC AND GOVERNMENT RESEARCH INSTITUTES
  • 8.7. OTHER END USERS

9. GEOGRAPHIC ANALYSIS

  • 9.1. INTRODUCTION
  • 9.2. NORTH AMERICA
  • 9.3. EUROPE
  • 9.4. ASIA
  • 9.5. REST OF THE WORLD (ROW)

10. COMPETITIVE LANDSCAPE

  • 10.1. INTRODUCTION
  • 10.2. STRATEGIC OVERVIEW
  • 10.3. LEADING PLAYERS IN THE CLINICAL TRIALS IMAGING MARKET
  • 10.4. COMPETITIVE SITUATION AND TRENDS
    • 10.4.1. AGREEMENTS, COLLABORATIONS, AND PARTNERSHIPS
    • 10.4.2. ACQUISITIONS
    • 10.4.3. NEW PRODUCT AND SERVICE LAUNCHES & PRODUCT UPGRADES
    • 10.4.4. EXPANSIONS
    • 10.4.5. OTHER DEVELOPMENTS

11. COMPANY PROFILES (Overview, Financials, Products & Services, Strategy, & Developments)*

  • 11.1. INTRODUCTION
  • 11.2. BIOCLINICA, INC.
  • 11.3. PAREXEL INTERNATIONAL CORPORATION
  • 11.4. ICON PUBLIC LIMITED COMPANY
  • 11.5. BIOMEDICAL SYSTEMS CORPORATION
  • 11.6. VIRTUALSCOPICS, INC.
  • 11.7. CARDIOVASCULAR IMAGING TECHNOLOGIES, LLC
  • 11.8. INTRINSIC IMAGING LLC
  • 11.9. IXICO PLC
  • 11.10. RADIANT SAGE LLC
  • 11.11. WORLDCARE CLINICAL, LLC

*Details on Financials, Product & Services, Strategy, & Developments might not be captured in case of unlisted companies.

12. APPENDIX

  • 12.1. INSIGHTS OF INDUSTRY EXPERTS
  • 12.2. DISCUSSION GUIDE
  • 12.3. OTHER DEVELOPMENTS
  • 12.4. INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
  • 12.5. AVAILABLE CUSTOMIZATIONS
  • 12.6. RELATED REPORTS

LIST OF TABLES

  • TABLE 1: CLINICAL TRIALS IMAGING MARKET SUMMARY
  • TABLE 2: INCREASE IN R&D SPENDING IS PROPELLING THE GROWTH OF THE CLINICAL TRIALS IMAGING MARKET
  • TABLE 3: HIGH IMPLEMENTATION COST OF IMAGING SYSTEMS TO RESTRAIN MARKET GROWTH
  • TABLE 4: EMERGING ECONOMIES OFFER SIGNIFICANT GROWTH OPPORTUNITIES
  • TABLE 5: HIGH COST OF CLINICAL TRIALS POSE A CHALLENGE FOR THE CLINICAL TRIALS IMAGING MARKET
  • TABLE 6: RISING DEMAND FOR MULTIMODALITY IMAGING TECHNOLOGY IN CLINICAL TRIALS IS A MAJOR TREND OBSERVED IN THIS MARKET
  • TABLE 7: CLINICAL TRIALS IMAGING MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 8: CLINICAL TRIALS IMAGING SERVICES MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 9: CLINICAL TRIALS IMAGING SERVICES MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 10: NORTH AMERICA: CLINICAL TRIALS IMAGING SERVICES MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 11: CLINICAL TRIALS IMAGING MARKET SIZE FOR OPERATIONAL IMAGING, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 12: NORTH AMERICA: CLINICAL TRIALS IMAGING MARKET SIZE FOR OPERATIONAL IMAGING, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 13: CLINICAL TRIALS IMAGING MARKET SIZE FOR READ ANALYSIS, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 14: NORTH AMERICA: CLINICAL TRIALS IMAGING MARKET SIZE FOR READ ANALYSIS, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 15: CLINICAL TRIALS IMAGING MARKET SIZE FOR SYSTEM AND TECHNICAL SUPPORT, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 16: NORTH AMERICA: CLINICAL TRIALS IMAGING MARKET SIZE FOR SYSTEM AND TECHNICAL SUPPORT, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 17: CLINICAL TRIALS IMAGING MARKET SIZE FOR TRIAL DESIGN CONSULTING, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 18: NORTH AMERICA: CLINICAL TRIALS IMAGING MARKET SIZE FOR TRIAL DESIGN CONSULTING, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 19: CLINICAL TRIALS IMAGING SOFTWARE MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 20: NORTH AMERICA: CLINICAL TRIALS IMAGING SOFTWARE MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 21: CLINICAL TRIALS IMAGING MARKET SIZE, BY MODALITY, 2013-2020 (USD MILLION)
  • TABLE 22: CLINICAL TRIALS IMAGING MARKET SIZE FOR CT, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 23: NORTH AMERICA: CLINICAL TRIALS IMAGING MARKET SIZE FOR CT, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 24: CLINICAL TRIALS IMAGING MARKET SIZE FOR MRI, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 25: NORTH AMERICA: CLINICAL TRIALS IMAGING MARKET SIZE FOR MRI, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 26: CLINICAL TRIALS IMAGING MARKET SIZE FOR ULTRASOUND, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 27: NORTH AMERICA: CLINICAL TRIALS IMAGING MARKET SIZE FOR ULTRASOUND, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 28: CLINICAL TRIALS IMAGING MARKET SIZE FOR PET, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 29: NORTH AMERICA: CLINICAL TRIALS IMAGING MARKET SIZE FOR PET, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 30: CLINICAL TRIALS IMAGING MARKET SIZE FOR X-RAY, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 31: NORTH AMERICA: CLINICAL TRIALS IMAGING MARKET SIZE FOR X-RAY, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 32: CLINICAL TRIALS IMAGING MARKET SIZE FOR ECHOCARDIOGRAPHY, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 33: NORTH AMERICA: CLINICAL TRIALS IMAGING MARKET SIZE FOR ECHOCARDIOGRAPHY, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 34: CLINICAL TRIALS IMAGING MARKET SIZE FOR OTHER MODALITIES, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 35: NORTH AMERICA: CLINICAL TRIALS IMAGING MARKET SIZE FOR OTHER MODALITIES, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 36: CLINICAL TRIALS IMAGING MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 37: CLINICAL TRIALS IMAGING MARKET SIZE FOR PHARMACEUTICAL COMPANIES, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 38: NORTH AMERICA: CLINICAL TRIALS IMAGING MARKET SIZE FOR PHARMACEUTICAL COMPANIES, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 39: CLINICAL TRIALS IMAGING MARKET SIZE FOR BIOTECHNOLOGY COMPANIES, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 40: NORTH AMERICA: CLINICAL TRIALS IMAGING MARKET SIZE FOR BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 41: CLINICAL TRIALS IMAGING MARKET SIZE FOR MEDICAL DEVICE MANUFACTURERS, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 42: NORTH AMERICA: CLINICAL TRIALS IMAGING MARKET SIZE FOR MEDICAL DEVICE MANUFACTURERS, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 43: CLINICAL TRIALS IMAGING MARKET SIZE FOR CROS, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 44: NORTH AMERICA: CLINICAL TRIALS IMAGING MARKET SIZE FOR CROS, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 45: CLINICAL TRIALS IMAGING MARKET SIZE FOR ACADEMIC AND GOVERNMENT RESEARCH INSTITUTES, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 46: NORTH AMERICA: CLINICAL TRIALS IMAGING MARKET SIZE FOR ACADEMIC AND GOVERNMENT RESEARCH INSTITUTES, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 47: CLINICAL TRIALS IMAGING MARKET SIZE FOR OTHER END USERS, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 48: NORTH AMERICA: CLINICAL TRIALS IMAGING MARKET SIZE FOR OTHER END USERS, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 49: CLINICAL TRIALS IMAGING MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 50: NORTH AMERICA: CLINICAL TRIALS IMAGING MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 51: NORTH AMERICA: CLINICAL TRIALS IMAGING MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 52: NORTH AMERICA: CLINICAL TRIALS IMAGING SERVICES MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 53: NORTH AMERICA: CLINICAL TRIALS IMAGING MARKET SIZE, BY MODALITY, 2013-2020 (USD MILLION)
  • TABLE 54: NORTH AMERICA: CLINICAL TRIALS IMAGING MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 55: EUROPE: CLINICAL TRIALS IMAGING MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 56: EUROPE: CLINICAL TRIALS IMAGING SERVICES MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 57: EUROPE: CLINICAL TRIALS IMAGING MARKET SIZE, BY MODALITY, 2013-2020 (USD MILLION)
  • TABLE 58: EUROPE: CLINICAL TRIALS IMAGING MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 59: ASIA: CLINICAL TRIALS IMAGING MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 60: ASIA: CLINICAL TRIALS IMAGING SERVICES MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 61: ASIA: CLINICAL TRIALS IMAGING MARKET SIZE, BY MODALITY, 2013-2020 (USD MILLION)
  • TABLE 62: ASIA: CLINICAL TRIALS IMAGING MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 63: ROW: CLINICAL TRIALS IMAGING MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 64: ROW: CLINICAL TRIALS IMAGING SERVICES MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 65: ROW: CLINICAL TRIALS IMAGING MARKET SIZE, BY MODALITY, 2013-2020 (USD MILLION)
  • TABLE 66: ROW: CLINICAL TRIALS IMAGING MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 67: RANK OF COMPANIES IN THE GLOBAL CLINICAL TRIALS IMAGING MARKET, 2015
  • TABLE 68: AGREEMENTS, COLLABORATIONS, AND PARTNERSHIPS WAS THE KEY STRATEGY ADOPTED BY PLAYERS BETWEEN JANUARY 2013 AND AUGUST 2015
  • TABLE 69: AGREEMENTS, COLLABORATIONS, AND PARTNERSHIPS, 2013-2015
  • TABLE 70: ACQUISITIONS, 2013-2015
  • TABLE 71: NEW PRODUCT AND SERVICE LAUNCHES & PRODUCT UPGRADES, 2013-2015
  • TABLE 72: EXPANSIONS, 2013-2015
  • TABLE 73: OTHER DEVELOPMENTS, 2013-2015
  • TABLE 74: MARKET DEVELOPMENTS BETWEEN JANUARY 2013 AND AUGUST 2015

LIST OF FIGURES

  • FIGURE 1: CLINICAL TRIALS IMAGING MARKET
  • FIGURE 2: RESEARCH DESIGN
  • FIGURE 3: MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH
  • FIGURE 4: MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
  • FIGURE 5: BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 6: DATA TRIANGULATION METHODOLOGY
  • FIGURE 7: CLINICAL TRIALS IMAGING MARKET SIZE, BY PRODUCT, 2015 VS. 2020 (USD MILLION)
  • FIGURE 8: CLINICAL TRIALS IMAGING MARKET SIZE, BY MODALITY, 2015 VS. 2020 (USD MILLION)
  • FIGURE 9: CLINICAL TRIALS IMAGING MARKET SIZE, BY END USER, 2015 VS. 2020 (USD MILLION)
  • FIGURE 10: CLINICAL TRIALS IMAGING MARKET: GEOGRAPHIC SNAPSHOT (2015)
  • FIGURE 11: CLINICAL TRIALS IMAGING MARKET SIZE, BY REGION, 2015 VS. 2020 (USD MILLION)
  • FIGURE 12: EMERGING ECONOMIES OFFER SIGNIFICANT GROWTH OPPORTUNITIES FOR MARKET GROWTH
  • FIGURE 13: SERVICES SEGMENT TO ACCOUNT FOR THE LARGEST MARKET SHARE IN 2015
  • FIGURE 14: ASIA TO WITNESS HIGHEST GROWTH RATE IN THE FORECAST PERIOD
  • FIGURE 15: NORTH AMERICA MARKET SEGMENT HEADED TOWARD MATURITY
  • FIGURE 16: CLINICAL TRIALS IMAGING MARKET: BY PRODUCT
  • FIGURE 17: CLINICAL TRIALS IMAGING MARKET: BY MODALITY
  • FIGURE 18: CLINICAL TRIALS IMAGING MARKET: BY END USER
  • FIGURE 19: INCREASE IN R&D SPENDING WILL DRIVE THE CLINICAL TRIALS IMAGING MARKET
  • FIGURE 20: INCREASING R&D FUNDING BOOSTING GROWTH IN THE CLINICAL TRIALS IMAGING MARKET
  • FIGURE 21: NUMBER OF BIOTECHNOLOGY PATENTS, BY COUNTRY, 2012
  • FIGURE 22: CLINICAL TRIALS IMAGING MARKET SEGMENTATION, BY PRODUCT
  • FIGURE 23: CLINICAL TRIALS IMAGING SERVICES TO FORM THE LARGEST SEGMENT IN 2015
  • FIGURE 24: OPERATIONAL IMAGING TO FORM THE LARGEST AND FASTEST-GROWING SEGMENT IN THE FORECAST PERIOD
  • FIGURE 25: NORTH AMERICA TO BE THE LARGEST SEGMENT OF THE CLINICAL TRIALS IMAGING SERVICES MARKET IN 2015
  • FIGURE 26: ASIA TO BE THE FASTEST-GROWING SEGMENT OF THE OPERATIONAL IMAGING MARKET IN THE FORECAST PERIOD
  • FIGURE 27: NORTH AMERICA TO FORM THE LARGEST SEGMENT OF THE READ ANALYSIS MARKET IN 2015
  • FIGURE 28: ASIA TO FORM THE FASTEST-GROWING SEGMENT OF THE SYSTEM AND TECHNICAL SUPPORT MARKET IN THE FORECAST PERIOD
  • FIGURE 29: NORTH AMERICA TO COMMAND LARGEST SHARE OF THE TRIAL DESIGN CONSULTING MARKET IN THE FORECAST PERIOD
  • FIGURE 30: ASIA TO BE THE FASTEST-GROWING SEGMENT OF THE CLINICAL TRIALS IMAGING SOFTWARE MARKET IN THE FORECAST PERIOD
  • FIGURE 31: CLINICAL TRIALS IMAGING MARKET SEGMENTATION, BY MODALITY
  • FIGURE 32: CT SEGMENT TO COMMAND THE LARGEST SHARE OF THE CLINICAL TRIALS IMAGING MARKET IN 2015
  • FIGURE 33: NORTH AMERICA EXPECTED TO DOMINATE THE CLINICAL TRIALS IMAGING MARKET FOR CT IN 2015
  • FIGURE 34: ASIA TO WITNESS HIGHEST GROWTH IN THE CLINICAL TRIALS IMAGING MARKET FOR MRI IN THE FORECAST PERIOD
  • FIGURE 35: NORTH AMERICA EXPECTED TO FORM THE LARGEST REGIONAL SEGMENT FOR ULTRASOUND IN 2015
  • FIGURE 36: ASIA EXPECTED TO BE THE FASTEST-GROWING REGIONAL SEGMENT FOR PET MARKET BETWEEN 2015 AND 2020
  • FIGURE 37: X-RAY MARKET IN ASIA TO WITNESS HIGHEST GROWTH IN THE FORECAST PERIOD
  • FIGURE 38: ECHOCARDIOGRAPHY MARKET IN ASIA TO WITNESS HIGHEST GROWTH IN THE FORECAST PERIOD
  • FIGURE 39: NORTH AMERICA DOMINATES THE MARKET FOR OTHER MODALITIES IN 2015
  • FIGURE 40: CLINICAL TRIALS IMAGING MARKET, BY END USER
  • FIGURE 41: CLINICAL TRIALS IMAGING MARKET SIZE, BY END USER, 2015 (USD MILLION)
  • FIGURE 42: NUMBER OF BIOTECHNOLOGY AND PHARMACEUTICAL PATENTS GRANTED IN 2012, BY REGION
  • FIGURE 43: PHARMACEUTICAL COMPANIES SEGMENT TO WITNESS HIGHEST GROWTH IN ASIA IN 2015
  • FIGURE 44: NORTH AMERICA TO BE THE LARGEST SEGMENT OF THE BIOTECHNOLOGY COMPANIES SEGMENT IN 2020
  • FIGURE 45: NORTH AMERICA TO DOMINATE THE CLINICAL TRIALS IMAGING MARKET FOR MEDICAL DEVICE MANUFACTURERS IN 2020
  • FIGURE 46: NORTH AMERICA EXPECTED TO DOMINATE THE CLINICAL TRIALS IMAGING MARKET FOR CROS IN 2020
  • FIGURE 47: PUBLIC-SECTOR RESEARCH FUNDING IS DRIVING THE GROWTH OF THE ACADEMIC & GOVERNMENT RESEARCH INSTITUTES END-USER SEGMENT
  • FIGURE 48: NORTH AMERICA DOMINATES THE MARKET FOR ACADEMIC AND GOVERNMENT RESEARCH INSTITUTES IN 2015
  • FIGURE 49: ASIA TO WITNESS THE HIGHEST GROWTH IN THE CLINICAL TRIALS IMAGING MARKET FOR OTHER END USERS IN THE FORECAST PERIOD
  • FIGURE 50: CLINICAL TRIALS IMAGING MARKET, BY REGION (MARKET SIZE AND GROWTH RATE), 2015-2020
  • FIGURE 51: CLINICAL TRIALS IMAGING MARKET IN ASIA EXPECTED TO GROW AT THE HIGHEST RATE FROM 2015 TO 2020
  • FIGURE 52: NORTH AMERICA: MARKET SNAPSHOT
  • FIGURE 53: U.S. FORMS THE FASTEST-GROWING MARKET IN NORTH AMERICA IN 2015
  • FIGURE 54: SERVICES ARE ESTIMATED TO BE THE LARGEST PRODUCT SEGMENT IN NORTH AMERICA (2015)
  • FIGURE 55: OPERATIONAL IMAGING LARGEST SERVICES SEGMENT IN NORTH AMERICA (2015)
  • FIGURE 56: CT EXPECTED TO FORM FOR THE LARGEST MODALITY SEGMENT IN NORTH AMERICA IN 2015
  • FIGURE 57: PHARMACEUTICAL COMPANIES TO FORM THE LARGEST END-USER SEGMENT IN NORTH AMERICA IN 2015
  • FIGURE 58: SERVICES TO FORM THE LARGEST PRODUCT SEGMENT IN EUROPE 2015
  • FIGURE 59: OPERATIONAL IMAGING ACCOUNTED FOR THE LARGEST SHARE IN THE EUROPEAN CLINICAL TRIALS IMAGING MARKET IN 2015
  • FIGURE 60: CT SEGMENT TO COMMAND THE LARGEST SHARE OF THE EUROPEAN CLINICAL TRIALS IMAGING MARKET IN 2015
  • FIGURE 61: PHARMACEUTICAL COMPANIES TO FORM THE LARGEST END-USER SEGMENT IN EUROPE IN 2015
  • FIGURE 62: ASIA: MARKET SNAPSHOT
  • FIGURE 63: SERVICES TO FORM THE LARGEST PRODUCT SEGMENT IN ASIA (2015)
  • FIGURE 64: OPERATIONAL IMAGING TO FORM THE LARGEST SERVICES SEGMENT IN ASIA IN 2015
  • FIGURE 65: CT SEGMENT TO ACCOUNT FOR THE LARGEST SHARE OF THE CLINICAL TRIALS IMAGING MARKET IN ASIA
  • FIGURE 66: PHARMACEUTICAL COMPANIES TO FORM THE LARGEST END-USER SEGMENT IN ASIA IN 2015
  • FIGURE 67: SERVICES TO FORM THE LARGEST PRODUCT SEGMENT IN THE ROW IN 2015
  • FIGURE 68: OPERATIONAL IMAGING TO COMMAND THE LARGEST SHARE IN THE ROW CLINICAL TRIALS IMAGING MARKET (2015)
  • FIGURE 69: CT TO FORM THE LARGEST MODALITY SEGMENT IN ROW IN 2015
  • FIGURE 70: PHARMACEUTICAL COMPANIES TO FORM THE LARGEST END-USER SEGMENT IN ROW IN 2015
  • FIGURE 71: AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS IS THE KEY GROWTH STRATEGY ADOPTED BY PLAYERS IN THE CLINICAL TRIALS IMAGING MARKET, 2013-2015
  • FIGURE 72: COMPANY SNAPSHOT: PAREXEL INTERNATIONAL CORPORATION
  • FIGURE 73: COMPANY SNAPSHOT: ICON PUBLIC LIMITED COMPANY
  • FIGURE 74: COMPANY SNAPSHOT: VIRTUALSCOPICS, INC.
  • FIGURE 75: COMPANY SNAPSHOT: IXICO PLC
Back to Top